📣Congratulations to Professor Brendan Jenkins, @saigenci.bsky.social's Program Lead for Tumour Inflammation and Immunotherapy, on being awarded the Japanese Cancer Association (JCA) International Award. The first Australian recipient! @jenkins-lab.bsky.social 👏

Thank you to the China International Talent Exchange Foundation for hosting our young ACE researchers! We shared our epigenetic research and cutting-edge technologies, whilst learning all about the pioneering research in Harbin, China. A wonderful exchange for ideas!🧪 @saigenci.bsky.social

📣Last night 90+ uni students attended the inaugural "Evening with Cancer Researchers". Hosted by @saigenci.bsky.social with representatives from University of Adelaide, UniSA's CCB and @sahmri.bsky.social. Great to see the enthusiasm of our next gen cancer researchers! @josundstrom.bsky.social 🔬

Welcome new @saigenci.bsky.social PhD students! SAiGENCI student reps Percy Zhang (Polo lab @acepigenetics.bsky.social ) and An Nguen were thrilled to welcome everyone with this warm gathering!

Next in our #AI webinars:

Stefano Mangiola @saigenci.bsky.social
talks AI models in #SingleCell and if they can uncover biological patterns

Anh TN Nguyen @monashuniversity.bsky.social shares how deep learning is accelerating #DrugDiscovery for GPCRs

More info www.biocommons.org.au/events/ai-se...

🧬 DNA’s message is only part of the story.

Dr @qizhang85.bsky.social @saigenci.bsky.social is decoding epigenetic modifiers - the hidden editors of gene expression - to uncover new cancer treatments.

🔗 More in our Impact Report: bit.ly/3EVhwD8

#DecodingTheUniverse #ScienceWeek

@saigenci.bsky.social are hiring! Work with our fabulous Group Leader, Dr Luke Isbel and the Molecular Epigenetics Laboratory. Luke is seeking a highly motivated, creative researcher to join his team. See all the details at careers.adelaide.edu.au/cw/en/job/51... @acepigenetics.bsky.social

📣On Friday, @saigenci.bsky.social hosted a delegation from the Chinese biomedical industry as part of the SJTU-AU Innovation Connect 2025 Australia Biomedical Inspection. Thanks to Lan Nguyen, Michael Roy, Fuji Li and Jing Xu representing @saigenci.bsky.social 👏

Join #AI and #Immunology!

📢 Fully funded #PhD @saigenci.bsky.social: develop AI to chart immune diversity across the population, in #cancer.

CV, transcript, and a one-page statement by 30 August 2025 → www.linkedin.com/feed/update/...

#PhDOpportunity #MachineLearning #SingleCell

Huge congrats to the ACE team led by Prof Polo, Dr Sullivan, Dr Bhattacharjee, as well as Prof Lister & Dr Pope on their MRFF Grant, tackling the challenge of helping patients with rare neural diseases! @saigenci.bsky.social @ryanlister.bsky.social @perkinsinstitute.bsky.social tinyurl.com/5t4e9x6n

@saigenci.bsky.social are excited to welcome two new researchers through a fellowship program funded by the Ainsworth Foundation. Dr Georgette Radford and Dr Tamsin Lannagan join the Tumour Inflammation and Immunotherapy program. Read more at www.adelaide.edu.au/newsroom/new... 🔬🧪👏

Great work Team @saigenci.bsky.social raising over $900 for cancer research at today's The Longest Table morning tea. Donations are still rolling in at www.thelongesttable.com.au/fundraisers/... Supporting THRFG. Together let's #forkcancer! 👊

📣 @saigenci.bsky.social thrilled to congratulate Professor Lan Nguyen awarded funding through the ARC's 2025 Future Fellowships scheme for his project "Deciphering contextual multi-pathway crosstalk in cellular decision making". @saigenci.bsky.social's first Future Fellow! bit.ly/4lobxqv 💻🔬👏

👏Congratulations to Dr Mohamed Saad on your @curecancer.bsky.social Researcher of the Year 2025 award. Proud to have you continuing your important work @saigenci.bsky.social! 🧪🔬👊 www.curecancer.com.au/blog/celebra...

📅 SAVE THE DATE - Our much-loved #PhD Course is turning 10!

🧬 This year, our unique, two-week course will be held at SAiGENCI & focus on #AI in #biology.

👉 For more info, to have your say on course content or to sponsor the event, visit our website: bit.ly/3GNpEpF

Updated results from Australian-led ENZAMET trial highlighting long-term outcomes with XTANDI® in mHSPC to be presented at #ASCO25. @saigenci.bsky.social Director @chrissweens1.bsky.social key leader in the ENZAMET study. Check out the full story at oncologynews.com.au/latest-news/...

📣 @saigenci.bsky.social are now on @bsky.app! Follow us for the latest news on our exciting research!